ReviewJournal of clinical medicine2025

Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.

Marco Infante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.